
For generations, families have watched loved ones disappear into the fog of Alzheimer’s disease. As memory fades and communication becomes challenging, many assume that the person they once knew and loved is gone forever. Most neuroscientists have accepted the idea that the dementia damage done to the brain is irreversible. Yet a handful of extraordinary observations challenge such an assumption. Could hidden memories in Alzheimer’s disease reappear under certain circumstances? A new case report in the journal Frontiers in Neuroscience (May 27, 2026) suggests that might be possible.
Could Psilocybin Unlock Hidden Memories in Alzheimer’s Disease?
In a moment I will share with you some amazing stories from readers of our national People’s Pharmacy newspaper column and website. They offer the possibility that some people with advanced dementia may retain surprising abilities that seem inaccessible most of the time. In a number of cases, hidden memories in Alzheimer’s disease appeared to re-emerge temporarily after treatment with opioid pain relievers.
But first, I want to present a remarkable new case report from Frontiers in Neuroscience (May 27, 2026). It involves the use of the hallucinogen psilocybin (magic mushrooms). It provides a glimpse of a provocative possibility: perhaps some patients who appear profoundly disconnected from the world around them still retain far more of themselves than anyone realizes. Could memories, personality and awareness persist even in the late stages of Alzheimer’s disease?
The case in question involves an 80-year-old Japanese-American women with advanced Alzheimer’s disease (AD). The woman had been declining for about 10 years.
During the previous five years she had become largely dependent on caregivers. According to the report, her speech was mostly limited to single words. She had difficulty walking, required help dressing, suffered from chronic urinary incontinence and rarely initiated conversations.
The physicians described her condition in medical terms:
“The longitudinal progressive neurodegenerative course, profound episodic memory impairment, language reduction, executive dysfunction, and functional decline were considered clinically most compatible with advanced Alzheimer’s disease.”
The medical intervention:
“A single oral dose of 5 g of psilocybin-containing mushrooms (Enigma strain) was administered during the initial intervention. One month later, a second supervised session using 3 g of psilocybin-containing mushrooms was performed due to persistence of clinically meaningful improvements, including sustained urinary continence.
“The intervention was exploratory and observational in nature, as no established psilocybin dosing framework currently exists for advanced dementia. The selected mushroom dose was relatively high compared with dosing approaches commonly used in modern clinical trials and was chosen based on prior experiential observations regarding depth and duration of psychedelic-induced neurobehavioral effects.”
The researchers described the outcome this way:
“Approximately 19 h after administration, the patient spontaneously initiated autobiographical conversation lasting several hours.
“During the second session, the patient remained significantly more verbally expressive throughout the experience and described emotionally positive imagery involving surfing with her son on a peaceful island. Facial expressivity, emotional reciprocity, spontaneous humor, and gait agility appeared markedly improved.”
According to the authors, the changes included:
- Restoration of urinary continence after years of incontinence
- Improved mobility and independent walking
- Dressing herself without assistance
- Increased emotional responsiveness
- Greater social engagement
- Retrieval of autobiographical memories
- Sustained conversations with family members
The authors were careful not to claim that Alzheimer’s disease had been reversed.
Instead, they concluded:
“Residual functional capacity may persist in advanced Alzheimer’s disease and may become transiently accessible following psilocybin-induced modulation of large-scale brain networks.”
That sentence may be the most important takeaway from the entire report. It might suggest that hidden memories in Alzheimer’s disease may still exist.
The investigators suggest that advanced AD may not destroy every aspect of memory and personality. Instead, some functions could remain latent or inaccessible, becoming temporarily available under unusual neurological circumstances.
In 2001 We Wrote That Hidden Memories in Alzheimer’s Disease Might Exist
Over two decades ago, we heard from an acquaintance who was a renowned healthcare provider. He told us that he got word his aging mother, who had severe Alzheimer’s disease, had fallen and broken two ribs. She was in the emergency department of the local hospital. He feared that she would be in even worse mental shape than usual because he knew that the emergency physicians would likely have given her a dose of opioids to control her pain.
I will let him relate the story himself:
Q. My 82-year-old mother has had Alzheimer’s for eight years. She sat all day and didn’t feed or bathe herself. Although she smiled pleasantly, she couldn’t retain working memory for more than two minutes. She repeated statements or questions over and over.
Last month she fell and broke two ribs. Her doctor put her on a narcotic pain reliever, hydrocodone (5 mg twice daily). A few days later she “woke up.”
She is talking, laughing and feeling quite sad to hear she has Alzheimer’s and that her close friend died three months ago. She is now dressing herself and putting on make-up for the first time in years. She told my sister, “What have you been doing to my hair? This is terrible and too light! I need a hair appointment tomorrow!”
Yesterday she opened up her phone directory and called three friends. She even supervised cooking dinner, though she hasn’t cooked for years. Have you ever heard of hydrocodone acting like this for Alzheimer’s disease?
Here is how we responded to this story about hidden memories in Alzheimer’s disease:
A. What an amazing story! We could not locate any research testing narcotics such as hydrocodone for Alzheimer’s disease.
More Stories about Hidden Memories in Alzheimer’s disease:
Even before we heard about the hydrocodone story we had received a similar anecdote. We did not publish it because it seemed so unusual. A woman in the final stages of Alzheimer’s disease was put on Oxycontin (oxycodone) for pain relief her last two weeks of life. During that time she was lucid and capable of communicating for the first time in months.
A few weeks later we got this message from another reader:
Q. I read the letter about a reversal of symptoms in an Alzheimer’s patient who was put on the pain reliever hydrocodone. My dad is a 90-year-old Alzheimer’s patient in an assisted living facility. I myself am a pharmacist, and I felt compelled to write to you.
About two years ago my father fell and broke his hip. He was taken to the emergency room and given a shot of the narcotic Demerol to control the pain. When I got there, expecting him to be even more confused than usual, he was absolutely lucid and answered all the ER doctor’s questions accurately.
My sister and I were flabbergasted and figured his clarity would end when they took him to surgery, but he came out of surgery quite lucid, like his old self. This lasted several days but slowly he regressed back to his forgetful Alzheimer’s self.
As a pharmacist, I tried to make sense of it. I discounted the Demerol and thought it must have been a physiological reaction to adrenaline. I told everyone about it–his neurologist, internist, orthopedist, other physicians, fellow pharmacists, drug reps, researchers at meetings–but no one had any explanation and we all thought it was a fluke.
Six months later my father fell and broke the other hip. Bingo. Once again he was lucid and like his old self after being put on an analgesic, but then slowly regressed.
Your column is the first time I have ever seen any mention of this phenomenon linked to narcotic pain relievers. I would love to get to the bottom of this for both personal and professional satisfaction.
Again we responded with surprise:
A. Yours is the fourth such amazing anecdote we have encountered. In each case, when an Alzheimer’s patient was given a narcotic analgesic, there was a significant, though temporary, improvement in the condition.
We have consulted some of the country’s leading experts on Alzheimer’s disease and they have no explanation. Although this may be a coincidence, we think it is so interesting that it ought to be studied scientifically.
Sadly, we have not discovered any research into these fascinating reports. Experts in the field discount the stories or just seem uninterested in following up. What a shame! It seems as if such anomalies deserve further study, even if the effect is temporary.
Additional Reader Stories Regarding Hidden Memories in Alzheimer’s Disease
After the original newspaper column appeared, readers from around the country described remarkably similar experiences.
“A New Mother”
“For many months, my mother has been unable to remember what she had for lunch only 15 minutes earlier. She is often unable to remember the names of her children and grandchildren. When asked a question regarding the past, she states, ‘I don’t know; that was too long ago.’
Since she has been in too much pain to participate in physical therapy, her doctor prescribed Lortab. When I arrived at the nursing home where she resides, I found a new mother. One who stated, ‘Well where did you come from?’ She laughed, joked and sang familiar songs with the great grandchildren all day and into the night. Her sitter reported this morning that she talked about her childhood and siblings until late in the evening, not wanting to go to sleep. The sitter said she had never seen her so expressive and able to convey her thoughts as well.
“She told us of events which occurred over 90 years ago, when the day before, she was unable to name her uncle when asked. She enquired about several relatives we thought she would have forgotten.
“One of her great granddaughters, smiled and stated, ‘Wow, I think Granny’s feeling better! She knows my name and that I like to ride horses!’
“Her family stood around the bed in amazement. I went to the nurses desk today ad asked if there had been a change of any kind in her medication and the only change was the addition of Lortab. Im so glad that I happened upon your article because now we know it’s not a fluke.”
“The Loveliest Evening”
Becky described her husband, diagnosed with dementia eight years earlier, who received oxycodone after oral surgery.
“We have had the loveliest evening. He is smiling, helping me with Christmas decorations. I was compelled to go to the Internet and now I see that it is a phenomenon.”
Will Scientists Pay Attention to the Idea that There Could Be Hidden Memories in Alzheimer’s Disease?
Before anyone gets the wrong idea, these reports do not prove that opioids or psilocybin treat Alzheimer’s disease.
The opioid stories are anecdotal observations. The psilocybin report involves only a single patient.
Scientists cannot determine cause and effect from such reports!
At the same time, medicine advances by paying attention to unexpected observations. Researchers often learn important lessons when real-world experiences fail to fit accepted theories.
The authors of the psilocybin paper repeatedly emphasize that they are not claiming disease reversal. Instead, they are proposing a hypothesis worthy of further investigation.
Here is their conclusion:
“Residual functional capacity may persist in advanced Alzheimer’s disease and may become transiently accessible following psilocybin-induced modulation of large-scale brain networks. Systematic investigation is warranted.”
Why These Reports of Hidden Memories in Alzheimer’s Disease Matter
For decades, Alzheimer’s disease has been viewed as a relentless process in which memories and personality are progressively erased.
The stories in this article suggest a different possibility. Perhaps some memories are not completely lost. Perhaps some aspects of identity remain present but inaccessible. Perhaps severe dementia sometimes reflects a failure of communication within damaged brain networks rather than total destruction of everything that once made a person who they were.
No one knows whether future research will validate these observations. But for families caring for loved ones with advanced dementia, the possibility is both scientifically intriguing and deeply moving. The person who seems absent may not be as far away as we imagine.
We sincerely hope some neuroscientist pays attention to the article in the journal Frontiers in Neuroscience (May 27, 2026). We hope that a researcher will read the anecdotes we have published in this People’s Pharmacy article and take them seriously. We think these cases deserve further scrutiny.
Final Words:
What do you think? We would love to hear any stories you might have to share about hidden memories in Alzheimer’s disease. We know this is not going to change the trajectory of this terrible disease, but it might open the door to some intriguing new research.
Do you know someone who might find this article of interest? If so, please send it via email or social media. You can do that easily by scrolling to the top of the page and clicking on an icon. Or you could just copy the URL and paste it into a message to a friend or family member. While you are at it, please encourage your acquaintances to sign up for our free newsletter. It is the only way we can get around the reality that our content is buried by Google almost as soon as it is published. Here is a link.
If you would like to support our work with a donation, we would also be extremely grateful. We are literally a “mom and pop” operation. Here is a link to the donation page. Thank you so much for supporting The People’s Pharmacy radio show/podcast and this website/newsletter.
Citations
- Lago, M., et al, "Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report," May 27, 2026, https://doi.org/10.3389/fnins.2026.1813281